The Follicular Lymphoma Foundation
The Follicular Lymphoma Foundation (FLF) is on a global mission to cure follicular lymphoma (FL). With patients at the heart of everything we do, we are leading the way in FL research and and treatment to ultimately find a cure and fast.
Founded by Nicola Mendelsohn CBE, the inspiration to establish FLF came three years after her diagnosis with FL. She joined the global conversation amongst FL patients in a Facebook group and listened to their questions as to why this cancer was still incurable despite decades of research. Today, with a growing international FL group of over 10,000 patients, the FLF can mobilise the patient as the driving force behind finding a cure.
Together, we can create a global community of researchers, clinicians, biotech and the pharmaceutical industry to accelerate positive outcomes.
Disclaimer: The videos are intended for educational and disease awareness purposes only and the information presented and discussed does not constitute medical advice.
Открытие лекарства от фолликулярной лимфомы | Наше влияние и видение
Nicky's Inspiring Speech | Unlock the Cure Gala 2025
Webinar: Choosing Your Next Treatment: What FL Patients Should Know
Meet our Investigator: Dr Michael Green
Webinar: Focus on Bispecific Antibody Treatment Options
Q&A with Dr Mitchell Smith - Charting Our Progress Towards a Cure Webinar
Webinar: Charting Our Progress Towards a Cure
Webinar: FL Treatment Options – What You Need to Know
Dr Mark Murakami's mission to CURE FL
Webinar: When FL Changes: Understanding Progression & Transformation
Webinar: FL and You – Emotional Health and Wellbeing
FLF’s Chief Medical Officer’s key highlights from the American Society of Hematology (ASH) 2024
Unlocking the Cure for Follicular Lymphoma 🌍
Andrew's Inspiring Speech | Unlock the Cure Gala 2024
Webinar: Cutting Edge Treatments for FL: What's New and What's Next?
Webinar: Relapsed Follicular Lymphoma Essential Insights
About the Follicular Lymphoma Foundation
Webinar: Understanding Follicular Lymphoma Clinical Trials
CMO on immunotherapy: why your voice matters
What is the potential for minimal residual disease in follicular lymphoma treatment?
CMO on immunotherapy: a breakthrough in follicular lymphoma treatment
CMO on improving T-cell engagement therapies: Can we make better CAR-Ts and bispecific antibodies?
Q&A with CURE FL investigator: Dr Patricia Pérez-Galán (English version)
Entrevista a la investigadora de CURE FL: Dra. Patricia Pérez-Galán (versión en Español)
Patient Paul shares his inspiring journey with follicular lymphoma
Why is our FL Biomarker Discovery Programme crucial to FL research?
How Can Patients Help Advance FL Research?
Webinar: How Close are we to Curing Follicular Lymphoma?
Webinar: An overview of Follicular Lymphoma